Leukotriene antagonist: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Created page with "{{subpages}} In pharmacology, '''leukotriene antagonists''' are "a class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the recepto...") |
imported>Robert Badgett No edit summary |
||
Line 2: | Line 2: | ||
In [[pharmacology]], '''leukotriene antagonists''' are "a class of drugs designed to prevent [[leukotriene]] synthesis or activity by blocking binding at the receptor level."<ref>{{MeSH}}</ref> | In [[pharmacology]], '''leukotriene antagonists''' are "a class of drugs designed to prevent [[leukotriene]] synthesis or activity by blocking binding at the receptor level."<ref>{{MeSH}}</ref> | ||
Leukotriene antagonists may help treat [[asthma]]. | Leukotriene antagonists may help treat [[asthma]].<ref name="pmid21542741">{{cite journal| author=Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RF et al.| title=Leukotriene antagonists as first-line or add-on asthma-controller therapy. | journal=N Engl J Med | year= 2011 | volume= 364 | issue= 18 | pages= 1695-707 | pmid=21542741 | doi=10.1056/NEJMoa1010846 | pmc= | url= }} </ref> | ||
==References== | ==References== | ||
<references/> | <references/> |
Latest revision as of 17:11, 23 August 2011
In pharmacology, leukotriene antagonists are "a class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level."[1]
Leukotriene antagonists may help treat asthma.[2]
References
- ↑ Anonymous (2024), Leukotriene antagonist (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RF et al. (2011). "Leukotriene antagonists as first-line or add-on asthma-controller therapy.". N Engl J Med 364 (18): 1695-707. DOI:10.1056/NEJMoa1010846. PMID 21542741. Research Blogging.